PBAC's latest decision on Amino acid formula without phenylalanine: Recommended (2016). Considered for Treatment of phenylketonuria (PKU) in adult patients. The submission requested an increase in maximum quantities to better meet the monthly protein requirements of adult PKU patients.
PBAC outcome
Recommended
Restricted
ICER (AUD/QALY)
Cost-min
cost-minimisation analysis
Submissions
2
first 2015
Submissions
2
2015 → 2016
Eligible population
Adult patients with phenylketonuria (PKU) requiring supplemented protein formulas.
Cost-minimisation analysis; no numeric ICER calculated. The sponsor estimated nil financial cost to PBS as all products are listed at the same price per gram of protein equivalent as their comparators.